Trials / Unknown
UnknownNCT03203070
Laparoscopic-guided TAP Block in Patients Undergoing Gastric Bypass
Laparoscopic-guided Transversus Abdominis Plane (TAP) Block for Postoperative Pain Control in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Hospital General Universitario Elche · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A prospective randomized trial will be performed. Patients undergoing gastric bypass will be randomized into 2 groups: patients undergoing laparoscopic-guided transversus abdominis plane (TAP) block as part of multimodal analgesia (Group 1), associated with postoperative intravenous analgesia, and patients receiving only postoperative intravenous analgesia (Group 2). Postoperative pain will be assessed with a Visual Analogic Scale 24h after surgery and morphine needs will be quantified.
Detailed description
A prospective randomized trial will be performed. Patients undergoing laparoscopic Roux-en-Y gastric bypass will be randomized into 2 groups: patients undergoing laparoscopic-guided TAP block with 30 ml Bupivacaine 0.5%, as part of multimodal analgesia (Group 1), associated with postoperative intravenous analgesia (Metamizol 2g/8h and Acetaminophen 1g/8h), and patients receiving only postoperative intravenous analgesia (Metamizol 2g/8h and Acetaminophen 1g/8h) (Group 2). Postoperative pain will be assessed with a Visual Analogic Scale 24 hours after surgery and morphine needs will be quantified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metamizol iv | Postoperative analgesia iv with Metamizol 2g/8h will be administered. |
| PROCEDURE | TAP block | Intraoperative laparoscopic-guided TAP block will be performed with 30ml Bupivacaine 0.5% |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2017-06-29
- Last updated
- 2017-06-29
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03203070. Inclusion in this directory is not an endorsement.